| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |